A sharp supply crunch is driving contract prices for mainstream DRAM memory chips up by as much as 95% quarter-on-quarter in early 2025, according to a revised forecast from market analyst TrendForce.
Global insurer Chubb Limited prepares to release its fourth-quarter financial results after Tuesday's market close, with investors weighing solid peer performances against broader sector headwinds.
While major indices grapple with uncertainty, a search for value is leading some investors to overlooked companies with strong fundamentals. We examine three such firms from Taiwan and Japan that are posting impressive growth despite sector headwinds.
While Italtile's stock saw an 11% bump last month, a look at the past five years reveals a sobering picture for long-term investors, with total shareholder returns deep in negative territory even as company earnings grew.
Japan's financial giant Nomura Holdings is scaling back risk at its digital asset unit following Q3 losses, a strategic pullback that mirrors wider pain across the crypto treasury sector as Bitcoin struggles to hold key levels.
As several stocks test their 52-week highs, we separate resilient momentum from potential mirages. We analyze one company capitalizing on long-term trends and two where caution may be warranted.
While several stocks have posted impressive short-term gains, a closer look reveals a divergence between fleeting catalysts and fundamental strength. We analyze one surging name with a solid foundation and two others where caution may be warranted.
While value investing promises bargains, some discounted stocks carry hidden risks. We examine three companies trading at low multiples but facing significant headwinds that warrant investor caution.
While recent surges in Trex, Robert Half, and Lemonade have captured investor attention, a closer look reveals valuation concerns and structural challenges that suggest their momentum may be fragile.
As IAC prepares to report quarterly results, investors are bracing for another potential revenue decline. We examine the key metrics, peer performance, and what the numbers could mean for the company's turnaround strategy.
As AI spending surges, investors face a classic choice: TSMC, the indispensable manufacturer powering the entire industry, or AMD, the aggressive designer aiming to dethrone Nvidia. We analyze the risk-reward calculus.
Initial drill results from the Senneville gold-silver-copper property in Quebec's prolific Val-d'Or camp have intersected significant near-surface mineralization, with intervals up to 57.8 meters, marking a promising start to the multi-phase exploration campaign.
As markets navigate uncertainty, a low-cost, diversified bond ETF is gaining renewed attention from investors seeking stable yield and portfolio ballast. We examine the strategy behind one popular fund and its role in a long-term income plan.
UK retail property specialist NewRiver REIT signals a resilient operational performance in its third quarter, driven by sustained consumer spending and strategic capital recycling, while navigating business rate changes.
A new forecast reveals streaming platforms are set to increase sports rights spending by 7% in 2026, with Amazon's Prime Video overtaking DAZN as the top investor, signaling a major shift in the battle for live sports dominance.
The semiconductor testing equipment leader capitalizes on surging AI chip demand to deliver historic Q3 results, while unveiling a significant treasury share cancellation and business segment reorganization aimed at enhancing shareholder value and operational focus.
Defense contractor L3Harris Technologies wins a significant U.S. Navy award to develop the Red Wolf long-range precision strike vehicle for the Marine Corps, underscoring the Pentagon's focus on advanced targeting capabilities and bolstering the company's portfolio in next-generation weapons.
Buoyed by robust quarterly and full-year results, Annaly Capital Management is pivoting more capital toward residential credit and mortgage servicing rights. The mortgage REIT's strategic shift aims to build on its earnings momentum while navigating an evolving interest rate landscape.
Immunocore Holdings (IMCR) shares have experienced notable turbulence, declining over 7% in a week. Yet, a significant gap between its current price and analyst fair value estimates highlights a debate over the biotech's future, heavily reliant on its lead asset KIMMTRAK and pipeline execution.
While trading near 52-week highs can signal strength, it can also precede a correction. We examine three stocks where current valuations may not justify the price tag, urging investors to look beyond the hype.
